Gastrointestinal events were the most common adverse events in both groups and generally occurred during dose escalation
Regarding collateral effects, the most commonly reported were gastrointestinal-related (diarrhea, nausea, vomiting, constipation) mainly occurring during the dose escalation period
These findings suggest that while bitter substances promise to improve glucose homeostasis, their potential adverse effects beyond the gastrointestinal system warrant careful consideration [196]
Whether GIP contributes 30% of the benefit or 50% matters less than the reality that adding it produces substantially better results
What Current Research Shows About Thyroid Cancer Risk Thyroid cancer was one of the first concerns raised about GLP-1 medications
During the consultation, the physician will evaluate the patient's medical history, discuss treatment options, and create a personalized plan